November 2016, Vol 6, No 11

Read More ›

Read More ›

Collaborative oncology care, which involves incorporating an advanced practitioner (AP) into an oncology practice, will help meet the growing burden of complex care and improve patient satisfaction. Read More ›

The Centers for Medicare & Medicaid Services (CMS) issued its “final” rule in mid-October for the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, and has permanently changed the face of cancer management for the rest of our lives. Read More ›

Read More ›

Read More ›

This detailed article of codes related to lung cancer is intended to assist practice managers and other healthcare providers and payers to ensure the proper use of coding and billing information associated with the treatment of patients with lung cancer. Read More ›

A clear set of standard operating procedures is at the heart of US Pharmacopeial Convention Chapter 800 (USP 800) compliance, according to Carol Yarrington, PharmD, BCOP, Oncology and Infusion Pharmacy Coordinator and Clinical Oncology Pharmacist, St. Joseph Mercy Health System, Ann Arbor, MI. At the recent Hematology/Oncology Pharmacy Association’s Oncology Pharmacy Practice Management Program conference, Dr Yarrington provided tips on how to address the new standard. Read More ›

Venetoclax (Venclexta) monotherapy has significant clinical activity in patients with acute myelogenous leukemia (AML) whose disease has relapsed or is resistant to chemotherapy and in those deemed unable to tolerate chemotherapy, according to a new study. Read More ›

Read More ›